Karnataka

Active

Goods

Re-Tender for the supply of Hypertension and Diabetes Tablets under NCD Gruha Arogya Program for 2025-26 Under State funds

Karnataka State Medical Supplies Corporation Limited

KSMSCL Managing Director office Bengaluru | Bangalore, Karnataka

Amount: Refer DocsCloses: 7 Nov 2026

Tenderkart AI

Reads all tender documents

Eligibility, documents, scope, Go/No-Go checksEligibility, required documents, scope of work and Go/No-Go checks for this tender, in one click.

Timeline

Published8 Oct 2026
Pre-Bid Meeting14 Oct 2026
Closes7 Nov 2026
Bid Opening9 Nov 2026

Tender Value

Refer Docs

EMD Value

₹31.2 L

Closing Date

7 Nov 2026, 5:30 pm

Tender Inviting Authority

Office Inviting Bids

Karnataka State Medical Supplies Corporation Limited

Contact Person

RAMESH MANAGER DRUGS

Office Number

Mobile Number

Work Description

Re-Tender for the supply of Hypertension and Diabetes Tablets under NCD Gruha Arogya Program for 2025-26 Under State funds

Tender Information

Tender ID

KSMSCL/2026-27/IND0421

Reference Number

KSMSCL/2026-27/IND0421

Tender Type

Open

Form of Contract

Two Tender Document System(Two Cover)

Location

KSMSCL Managing Director office Bengaluru

Source Website

Subscribe to view

Documents Required

35 documents required · 35 mandatory

Technical Bid

RequiredAnnual Turnover, Non-MSE-3 years and MSE-2 years.

RequiredAny other relevant document required as per the tender terms and conditions.

RequiredAppendix 2 & Appendix-2A DESIGNS FOR LOGOGRAMS

RequiredAppendix 3 SCHEDULES FOR PACKAGING OF DRUGS AND MEDICINES.

RequiredAppendix 4 BARCODE REQUIREMENTS AT SHIPPER/CARTON/TERTAIRY LEVEL PACKAGING.

RequiredAppendix 7 Checklist of Documents uploaded Mark the Attached Documents

RequiredAttested copy of Specimen Label Annexure-VIII.

RequiredAudited Statement of Accounts viz. Balance Sheet, Trading/Profit and Loss Account, Non-MSE-3 years and MSE-2 years.

RequiredCapacity Installation Certificate Annexure-IV.

RequiredCertificate issued by the Chartered Accountant as per Annexure II with UDIN Number.

RequiredCertificates issued by Drug Control Department/FDA towards in-house lab approval/details of NABL lab where the quality testing for the quoted drug will be done is to be furnished at the time of submission of Technical Bid/before issuing NOA as per Annexure XIV.

RequiredDeclaration Annexure XII.

RequiredDetails of Bidder Annexure I.

RequiredF.F.S Technology Certificate, Annexure-XI.

RequiredGeneral Power of Attorney Annexure XIII

RequiredGST Registration certificate.

RequiredGST remittance for a period of 3 months up to 31st March 2026.

RequiredIT Returns, Non-MSE-3 years and MSE-2 years.

RequiredManufacturing License

RequiredManufacturing Unit Annexure-III.

RequiredMarket Standing Certificate Annexure-VI.

RequiredNon Conviction Certificate NOC Annexure-IX.

RequiredNSIC registration certificate The EMD for MSE units Registered under NSIC single point registration system of the Government of India is exempted. The bidder shall select the relevant option in the portal against EMD payment clause and upload the NSIC registration certificate.

RequiredOffered Supply Capacity and Lead Time Required Annexure VII.

RequiredOriginal valid SSI, MSME, UDYAM MSME certificates.

RequiredPerformance Certificate Annexure-XA/B

RequiredProduct Certification.

RequiredProduct Permission for the drug in IP/BP/USP in addition to previous Product Permission for that drug official in IP/BP/USP. Supporting documents if any to be uploaded.

RequiredProduct Permission/Approval.

RequiredProduct Quoted under this Tender Annexure V.

RequiredRegistration certificate such as Incorporation Certificate, Registration of Firms, Partnership deed, Establishment registration Certificate etc.

RequiredScanned copy of the DD Drawn/NEFT/RTGS copy with UTR No/Transaction ID towards tender processing fee Rs. 5900/-.

RequiredSECTION IX Earnest Money Deposit Form.

RequiredSECTION IXB Earnest Money Deposit Bank Guarantee.

RequiredSECTION VIII Tender Form.

Eligibility Criteria

Tenderers should not be associated, or have been associated in the past, directly or indirectly, with a firm or any of its affiliates which have been engaged by the Purchaser to provide consulting services for the preparation of the design, specifications, and other documents to be used for the procurement of the goods to be purchased under this Invitation of Tenders.

Bidders shall not be under a declaration of ineligibility for corrupt and fraudulent practices issued by Government of Karnataka

It shall be the responsibility of the Bidder to ensure credit of Tender Processing Fee and EMD into the respective receiving bank accounts of e-Procurement on or before the last date and time of bid submission.

EMD Payments through e-Payment mode shall be made as one single transaction and payments made in part are liable for rejection.

Technical Criteria

Others

As per Tender Document

Others -- As per Tender Document

Fee & Financial Details

Tender Fee Amount

₹500

EMD Fee Amount

₹31.2 L

Important Dates

Last Activity

8 Oct 2026

Published

8 Oct 2026

Bid Opening

9 Nov 2026

Download Ends

15 Oct 2026

Pre-Bid Meeting

14 Oct 2026

BOQ Preview

•

Glimepiride Tablet IP 1mg 1 x1

•

Metformin Hydrochloride Sustained release Tablet IP 500 mg 1x1

•

Telmisartan Tablet IP 40 mg 1 x 1

•

Amlodipine Tablet IP 5 mg 1 x 1

Documents

Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.

NIT Documents

IND-0421 TENDER DOCUMENT NCD DRUGS.docx

Tender Document • 1.07 MB

Ready to Participate?

Download all tender documents and submit your bid

Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .

Loading…

Karnataka

Active

Goods

Re-Tender for the supply of Hypertension and Diabetes Tablets under NCD Gruha Arogya Program for 2025-26 Under State funds

Karnataka State Medical Supplies Corporation Limited

KSMSCL Managing Director office Bengaluru | Bangalore, Karnataka

Amount: Refer DocsCloses: 7 Nov 2026

Tenderkart AI

Reads all tender documents

Eligibility, documents, scope, Go/No-Go checksEligibility, required documents, scope of work and Go/No-Go checks for this tender, in one click.

Timeline

Published8 Oct 2026
Pre-Bid Meeting14 Oct 2026
Closes7 Nov 2026
Bid Opening9 Nov 2026

Tender Value

Refer Docs

EMD Value

₹31.2 L

Closing Date

7 Nov 2026, 5:30 pm

Tender Inviting Authority

Office Inviting Bids

Karnataka State Medical Supplies Corporation Limited

Contact Person

RAMESH MANAGER DRUGS

Office Number

Mobile Number

Work Description

Re-Tender for the supply of Hypertension and Diabetes Tablets under NCD Gruha Arogya Program for 2025-26 Under State funds

Tender Information

Tender ID

KSMSCL/2026-27/IND0421

Reference Number

KSMSCL/2026-27/IND0421

Tender Type

Open

Form of Contract

Two Tender Document System(Two Cover)

Location

KSMSCL Managing Director office Bengaluru

Source Website

Subscribe to view

Documents Required

35 documents required · 35 mandatory

Technical Bid

RequiredAnnual Turnover, Non-MSE-3 years and MSE-2 years.

RequiredAny other relevant document required as per the tender terms and conditions.

RequiredAppendix 2 & Appendix-2A DESIGNS FOR LOGOGRAMS

RequiredAppendix 3 SCHEDULES FOR PACKAGING OF DRUGS AND MEDICINES.

RequiredAppendix 4 BARCODE REQUIREMENTS AT SHIPPER/CARTON/TERTAIRY LEVEL PACKAGING.

RequiredAppendix 7 Checklist of Documents uploaded Mark the Attached Documents

RequiredAttested copy of Specimen Label Annexure-VIII.

RequiredAudited Statement of Accounts viz. Balance Sheet, Trading/Profit and Loss Account, Non-MSE-3 years and MSE-2 years.

RequiredCapacity Installation Certificate Annexure-IV.

RequiredCertificate issued by the Chartered Accountant as per Annexure II with UDIN Number.

RequiredDeclaration Annexure XII.

RequiredDetails of Bidder Annexure I.

RequiredF.F.S Technology Certificate, Annexure-XI.

RequiredGeneral Power of Attorney Annexure XIII

RequiredGST Registration certificate.

RequiredGST remittance for a period of 3 months up to 31st March 2026.

RequiredIT Returns, Non-MSE-3 years and MSE-2 years.

RequiredManufacturing License

RequiredManufacturing Unit Annexure-III.

RequiredMarket Standing Certificate Annexure-VI.

RequiredNon Conviction Certificate NOC Annexure-IX.

RequiredOffered Supply Capacity and Lead Time Required Annexure VII.

RequiredOriginal valid SSI, MSME, UDYAM MSME certificates.

RequiredPerformance Certificate Annexure-XA/B

RequiredProduct Certification.

RequiredProduct Permission for the drug in IP/BP/USP in addition to previous Product Permission for that drug official in IP/BP/USP. Supporting documents if any to be uploaded.

RequiredProduct Permission/Approval.

RequiredProduct Quoted under this Tender Annexure V.

RequiredRegistration certificate such as Incorporation Certificate, Registration of Firms, Partnership deed, Establishment registration Certificate etc.

RequiredScanned copy of the DD Drawn/NEFT/RTGS copy with UTR No/Transaction ID towards tender processing fee Rs. 5900/-.

RequiredSECTION IX Earnest Money Deposit Form.

RequiredSECTION IXB Earnest Money Deposit Bank Guarantee.

RequiredSECTION VIII Tender Form.

Eligibility Criteria

Bidders shall not be under a declaration of ineligibility for corrupt and fraudulent practices issued by Government of Karnataka

EMD Payments through e-Payment mode shall be made as one single transaction and payments made in part are liable for rejection.

Technical Criteria

Others

As per Tender Document

Others -- As per Tender Document

Fee & Financial Details

Tender Fee Amount

₹500

EMD Fee Amount

₹31.2 L

Important Dates

Last Activity

8 Oct 2026

Published

8 Oct 2026

Bid Opening

9 Nov 2026

Download Ends

15 Oct 2026

Pre-Bid Meeting

14 Oct 2026

BOQ Preview

•

Glimepiride Tablet IP 1mg 1 x1

•

Metformin Hydrochloride Sustained release Tablet IP 500 mg 1x1

•

Telmisartan Tablet IP 40 mg 1 x 1

•

Amlodipine Tablet IP 5 mg 1 x 1

Documents

Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.

NIT Documents

IND-0421 TENDER DOCUMENT NCD DRUGS.docx

Tender Document • 1.07 MB

Ready to Participate?

Download all tender documents and submit your bid